ID Genomics has received nearly $300,000 under a Phase I STTR grant from National Institutes of Health (NIH) entitled “Rapid Genetic Fingerprinting of SARS-Cov-2 Variants”

By IDG Admin 3 months ago
Home  /  News  /  ID Genomics has received nearly $300,000 under a Phase I STTR grant from National Institutes of Health (NIH) entitled “Rapid Genetic Fingerprinting of SARS-Cov-2 Variants”

The funding will help accelerate the commercialization of the company's dipstick-based assay, which is designed to identify many SARS-CoV-2 genetic variants at once.

Category:
  News
this post was shared 0 times
 000